{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T08:15:35Z","timestamp":1792656935399,"version":"4.5.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2007,12,1]],"date-time":"2007-12-01T00:00:00Z","timestamp":1196467200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,12,1]],"date-time":"2007-12-01T00:00:00Z","timestamp":1196467200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","joms.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Oral and Maxillofacial Surgery"],"published-print":{"date-parts":[[2007,12]]},"DOI":"10.1016\/j.joms.2007.08.003","type":"journal-article","created":{"date-parts":[[2007,11,27]],"date-time":"2007-11-27T09:13:15Z","timestamp":1196154795000},"page":"2397-2410","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":591,"title":["Oral Bisphosphonate-Induced Osteonecrosis: Risk Factors, Prediction of Risk Using Serum CTX Testing, Prevention, and Treatment"],"prefix":"10.1016","volume":"65","author":[{"given":"Robert E.","family":"Marx","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr","given":"Joseph E.","family":"Cillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan J.","family":"Ulloa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.joms.2007.08.003_bib1","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/S0278-2391(03)00720-1","article-title":"Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: A growing epidemic","volume":"61","author":"Marx","year":"2003","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.joms.2007.08.003_bib2","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1016\/j.joms.2005.07.010","article-title":"Bisphosphonate induced exposed bone (osteonecrosis\/osteopetrosis) of the jaws: Risk factors, recognition, prevention and treatment","volume":"63","author":"Marx","year":"2005","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.joms.2007.08.003_bib3","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.joms.2004.02.004","article-title":"Osteonecrosis of the jaws associated with the use of bisphosphonates: A review of 63 cases","volume":"62","author":"Ruggerio","year":"2004","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.joms.2007.08.003_bib4","doi-asserted-by":"crossref","first-page":"417","DOI":"10.5694\/j.1326-5377.2005.tb06762.x","article-title":"Bisphosphonates and osteonecrosis of the jaw","volume":"182","author":"Purcell","year":"2005","journal-title":"Med J Aust"},{"key":"10.1016\/j.joms.2007.08.003_bib5","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/cncr.21130","article-title":"Bisphosphonate associated osteonecrosis of mandibular and maxillary bone: An emerging oral complication of supportive cancer therapy","volume":"104","author":"Migliorati","year":"2005","journal-title":"Cancer"},{"key":"10.1016\/j.joms.2007.08.003_bib6","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.oraloncology.2005.08.001","article-title":"Jaw osteonecrosis associated with bisphosphonates multiple exposed areas and its relationship to teeth extractions","volume":"42","author":"Bagan","year":"2006","journal-title":"Oral Oncol"},{"key":"10.1016\/j.joms.2007.08.003_bib7","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/j.tripleo.2006.10.010","article-title":"Osteonecrosis of the jaws associated with use of residronate","volume":"103","author":"Brooks","year":"2007","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"10.1016\/j.joms.2007.08.003_bib8","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.joms.2006.10.061","article-title":"Nature and frequency of bisphosphonate associated osteonecrosis of the jaws in Australia","volume":"65","author":"Mavrokoski","year":"2007","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.joms.2007.08.003_bib9","first-page":"8","article-title":"Oral bisphosphonates and osteonecrosis of the jaw","volume":"55","author":"Wynn","year":"2007","journal-title":"Gen Dent"},{"key":"10.1016\/j.joms.2007.08.003_bib10","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.joms.2006.11.003","article-title":"American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws","volume":"65","year":"2007","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.joms.2007.08.003_bib11","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1385\/JCD:2:3:275","article-title":"Classification of osteoporosis and osteopenia in postmenopausal women in dependent on site-specific analysis","volume":"2","author":"Varney","year":"1999","journal-title":"J Clin Densitom"},{"key":"10.1016\/j.joms.2007.08.003_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1385\/JCD:7:1:1","article-title":"Official positions of the International Society for Clinical Densitometry","volume":"7","author":"Leib","year":"2007","journal-title":"J Clin Densitom"},{"key":"10.1016\/j.joms.2007.08.003_bib13","first-page":"1","article-title":"Practical guidelines: ACOG releases guidelines for clinical management of osteoporosis","volume":"69","author":"Neff","year":"2004","journal-title":"Am Fam Physician"},{"key":"10.1016\/j.joms.2007.08.003_bib14","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1345\/aph.1E357","article-title":"Discovery, clinical development, and therapeutic uses of bisphosphonate","volume":"39","author":"Licata","year":"2005","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.joms.2007.08.003_bib15","series-title":"Product information (Fosamax)","year":"2005"},{"key":"10.1016\/j.joms.2007.08.003_bib16","series-title":"Product information (Actonel)","year":"2005"},{"key":"10.1016\/j.joms.2007.08.003_bib17","doi-asserted-by":"crossref","first-page":"107","DOI":"10.2165\/00044011-200525020-00003","article-title":"Pharmacokinetic considerations in determining the terminal elimination half-lives of bisphosphonates","volume":"25","author":"Lasseter","year":"2005","journal-title":"Clin Drug Invest"},{"key":"10.1016\/j.joms.2007.08.003_bib18","series-title":"Product information sheet, Aredia","year":"2001"},{"key":"10.1016\/j.joms.2007.08.003_bib19","series-title":"Zometa","year":"2004"},{"key":"10.1016\/j.joms.2007.08.003_bib20","doi-asserted-by":"crossref","first-page":"2961","DOI":"10.1002\/1097-0142(20000615)88:12+<2961::AID-CNCR12>3.0.CO;2-L","article-title":"Cellular and molecular mechanisms of action of bisphosphonates","volume":"88","author":"Rogers","year":"2000","journal-title":"Cancer"},{"key":"10.1016\/j.joms.2007.08.003_bib21","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1210\/jc.2004-0952","article-title":"Severely suppressed bone turnover: A potential complication of Alendronate therapy","volume":"90","author":"Adoina","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.joms.2007.08.003_bib22","first-page":"2579","article-title":"Bone turnover in elderly canine mandibles and tibia","volume":"76","author":"Dixon","year":"1997","journal-title":"J Dent Res"},{"key":"10.1016\/j.joms.2007.08.003_bib23","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1002\/ar.1091960210","article-title":"Dynamic histomorphometry of alveolar bone remodeling in the adult rat","volume":"196","author":"Viznery","year":"1980","journal-title":"Anat Rec"},{"key":"10.1016\/j.joms.2007.08.003_bib24","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1177\/08959374990130012301","article-title":"In vivo bone response to biochemical loading at the bone\/dental-implant interface","volume":"13","author":"Brunski","year":"1999","journal-title":"Adv Dent Res"},{"key":"10.1016\/j.joms.2007.08.003_bib25","series-title":"Risks, prevention, and management of intravenous bisphosphonate-induced osteonecrosis of the jaws","first-page":"77","year":"2006"},{"key":"10.1016\/j.joms.2007.08.003_bib26","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0889-8529(05)70007-4","article-title":"Biochemical markers of bone turnover: Applications for osteoporosis","volume":"27","author":"Garnero","year":"1998","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.1016\/j.joms.2007.08.003_bib27","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s002239900541","article-title":"Utility of biochemical markers of bone turnover in the follow-up of patients treated with bisphosphonates","volume":"63","author":"Rosen","year":"1998","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.joms.2007.08.003_bib28","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1007\/PL00005830","article-title":"Serum CTX","volume":"66","author":"Rosen","year":"2000","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.joms.2007.08.003_bib29","series-title":"FDA publication 04-1322C","year":"2004"},{"key":"10.1016\/j.joms.2007.08.003_bib30","doi-asserted-by":"crossref","first-page":"4118","DOI":"10.1210\/jcem.85.11.6953","article-title":"Fracture risk reduction with alendronate in women with osteoporosis: The Fracture Intervention Trial","volume":"85","author":"Black","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.joms.2007.08.003_bib31","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1056\/NEJM199511303332201","article-title":"Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis","volume":"333","author":"Liberman","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.joms.2007.08.003_bib32","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1007\/s001980070037","article-title":"Effects of body size and skeletal site on the estimated prevalence of osteoporosis in women and men","volume":"11","author":"Melton","year":"2000","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.joms.2007.08.003_bib33","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0002-9343(01)01124-X","article-title":"Improvement in spine bone density and reduction in risk of vertebral fractures during treatment with antiresorptive drugs","volume":"112","author":"Cummings","year":"2002","journal-title":"Am J Med"},{"key":"10.1016\/j.joms.2007.08.003_bib34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1359\/jbmr.2002.17.1.1","article-title":"Relationships between bone mineral density and incident vertebral fracture risk with raloxifene therapy","volume":"17","author":"Sarkar","year":"2002","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.joms.2007.08.003_bib35","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1210\/edrv.23.1.0453","article-title":"Antiresorptive treatment of postmenopausal osteoporosis: Comparison of study designs and outcomes in large clinical trials with fracture as an endpoint","volume":"23","author":"Marcus","year":"2002","journal-title":"Endocr Rev"},{"key":"10.1016\/j.joms.2007.08.003_bib36","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1056\/NEJMoa030897","article-title":"Ten years experience with alendronate for osteoporosis in postmenopausal women","volume":"350","author":"Bone","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.joms.2007.08.003_bib37","doi-asserted-by":"crossref","first-page":"2927","DOI":"10.1001\/jama.296.24.2927","article-title":"Effects of continuing or stopping alendronate after 5 years of treatment: The Fracture Intervention Trial Long-term Extension (FLEX): A randomized trial","volume":"296","author":"Black","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.joms.2007.08.003_bib38","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.ajodo.2006.11.002","article-title":"Orthodontic treatment of patients using bisphosphonates: A report of 2 cases","volume":"131","author":"Rinchuse","year":"2007","journal-title":"Am J Orthod Dentofacial Orthop"},{"key":"10.1016\/j.joms.2007.08.003_bib39","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.ajodo.2006.09.035","article-title":"Bisphosphonate treatment: An orthodontic concern calling for a proactive approach","volume":"131","author":"Zahorski","year":"2007","journal-title":"Am J Orthod Dentofacial Orthop"},{"key":"10.1016\/j.joms.2007.08.003_bib40","first-page":"349","article-title":"Safety of oral bisphosphonates: Controlled studies on alveolar bone","volume":"21","author":"Jeffcoat","year":"2006","journal-title":"Int J Oral Maxillofac Implants"}],"container-title":["Journal of Oral and Maxillofacial Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278239107015947?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278239107015947?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T16:22:03Z","timestamp":1759508523000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278239107015947"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,12]]},"references-count":40,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2007,12]]}},"alternative-id":["S0278239107015947"],"URL":"https:\/\/doi.org\/10.1016\/j.joms.2007.08.003","relation":{},"ISSN":["0278-2391"],"issn-type":[{"value":"0278-2391","type":"print"}],"subject":[],"published":{"date-parts":[[2007,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Oral Bisphosphonate-Induced Osteonecrosis: Risk Factors, Prediction of Risk Using Serum CTX Testing, Prevention, and Treatment","name":"articletitle","label":"Article Title"},{"value":"Journal of Oral and Maxillofacial Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.joms.2007.08.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 American Association of Oral and Maxillofacial Surgeons. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}